KalVista is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet needs.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources |
March 16, 2018KalVista Pharmaceuticals Reports Fiscal Third Quarter Results
March 05, 2018KalVista Pharmaceuticals to Present at 30th Annual ROTH Conference
More News
|